The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Boston Scientific (NYSE:BSX) faced a 4.3% dip in its stock price following the news of a temporary pause in the trial for its FARAPULSE Pulse Field Ablation system. The pause comes as the company ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...